These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35114407)

  • 21. The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.
    Wade-Evans AM; Woolhouse T; O'Hara R; Hamblin C
    J Virol Methods; 1993 Dec; 45(2):179-88. PubMed ID: 8113344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Genome Analysis of All Nine African Horse Sickness Serotypes Isolated From Equine Fatalities in Kenya and South Africa.
    Hoffmann B; Joseph S; Patteril NAG; Caveney MR; Elizabeth SK; Muhammed R; Wernery R; Wernery U
    J Equine Vet Sci; 2022 Dec; 119():104137. PubMed ID: 36223818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Luminex-Based DIVA Assay for Serological Detection of African Horse Sickness Virus in Horses.
    Sánchez-Matamoros A; Nieto-Pelegrín E; Beck C; Rivera-Arroyo B; Lecollinet S; Sailleau C; Zientara S; Sánchez-Vizcaíno JM
    Transbound Emerg Dis; 2016 Aug; 63(4):353-9. PubMed ID: 27090377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV).
    van Rijn PA; van de Water SG; Feenstra F; van Gennip RG
    Virol J; 2016 Jul; 13():119. PubMed ID: 27368544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real time RT-PCR assays for detection and typing of African horse sickness virus.
    Bachanek-Bankowska K; Maan S; Castillo-Olivares J; Manning NM; Maan NS; Potgieter AC; Di Nardo A; Sutton G; Batten C; Mertens PP
    PLoS One; 2014; 9(4):e93758. PubMed ID: 24721971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology of African horse sickness virus based on analyses and comparisons of genome segments 7 and 10.
    Zientara S; Sailleau C; Plateau E; Moulay S; Mertens PP; Crucière C
    Arch Virol Suppl; 1998; 14():221-34. PubMed ID: 9785509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the three-dimensional structure of the African horse sickness virus VP7 trimer by homology modelling.
    Bekker S; Burger P; van Staden V
    Virus Res; 2017 Mar; 232():80-95. PubMed ID: 28167267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.
    van Gennip RGP; van de Water SGP; Potgieter CA; van Rijn PA
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.
    Lulla V; Lulla A; Wernike K; Aebischer A; Beer M; Roy P
    J Virol; 2016 Aug; 90(16):7405-7414. PubMed ID: 27279609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.
    Kanai Y; van Rijn PA; Maris-Veldhuis M; Kaname Y; Athmaram TN; Roy P
    Vaccine; 2014 Sep; 32(39):4932-7. PubMed ID: 25045805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. African horse sickness virus structure.
    Roy P; Mertens PP; Casal I
    Comp Immunol Microbiol Infect Dis; 1994; 17(3-4):243-73. PubMed ID: 8001348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
    van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
    Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
    Chiam R; Sharp E; Maan S; Rao S; Mertens P; Blacklaws B; Davis-Poynter N; Wood J; Castillo-Olivares J
    PLoS One; 2009 Jun; 4(6):e5997. PubMed ID: 19543394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of chicken IgY in a double antibody sandwich ELISA for detecting African horsesickness virus.
    Du Plessis DH; Van Wyngaardt W; Romito M; Du Plessis M; Maree S
    Onderstepoort J Vet Res; 1999 Mar; 66(1):25-8. PubMed ID: 10396758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.
    Maree S; Durbach S; Huismans H
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():333-7. PubMed ID: 9472617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VP7 from African horse sickness virus serotype 9 protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara RS; Burroughs JN; Mertens PP
    Arch Virol Suppl; 1998; 14():211-9. PubMed ID: 9785508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and serological surveillance of African horse sickness virus in eastern and central Saudi Arabia.
    Hemida MG; Alhammadi M; Daleb A; Alnaeem A
    Rev Sci Tech; 2017 Dec; 36(3):889-898. PubMed ID: 30160693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of probes for typing African horsesickness virus isolates using a complete set of cloned VP2-genes.
    Koekemoer JJ; Potgieter AC; Paweska JT; Van Dijk AA
    J Virol Methods; 2000 Aug; 88(2):135-44. PubMed ID: 10960701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.
    Zwart L; Potgieter CA; Clift SJ; van Staden V
    PLoS One; 2015; 10(4):e0124281. PubMed ID: 25915516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.